We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
-15.01%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
-$695M
Cap. Flow
-$325M
Cap. Flow %
-21.92%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
4
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$12.8M
2
PRTA icon
Prothena Corp
PRTA
+$9.11M
3
BIIB icon
Biogen
BIIB
+$3.36M
4
TBPH icon
Theravance Biopharma
TBPH
+$1.21M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$344M
2
GILD icon
Gilead Sciences
GILD
+$6.55M
3
BIVV
Bioverativ Inc. Common Stock
BIVV
+$657K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
1
Prothena Corp
PRTA
$448M
$432M 29.14%
11,528,614
+179,000
+2% +$9.11M
ALKS icon
2
Alkermes
ALKS
$8.11B
$415M 27.99%
7,585,683
+250,000
+3% +$12.8M
TBPH icon
3
Theravance Biopharma
TBPH
$877M
$300M 20.21%
10,747,108
+41,000
+0.4% +$1.21M
BIIB icon
4
Biogen
BIIB
$30.5B
$118M 7.96%
370,564
+10,480
+3% +$3.36M
GILD icon
5
Gilead Sciences
GILD
$163B
$113M 7.63%
1,579,353
-86,239
-5% -$6.55M
BIVV
6
DELISTED
Bioverativ Inc. Common Stock
BIVV
$105M 7.08%
1,948,325
-12,000
-0.6% -$657K
ABBV icon
7
AbbVie
ABBV
$430B
– –
-3,875,358
Closed -$344M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 2.79% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Woodford Investment Management held 7 positions worth $1.48B, down 32% from $2.18B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management withdrew a net $325M in Q4 2017, closing 1 position and reducing 2 holdings. Its most notable exit was AbbVie, an estimated $344M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Woodford Investment Management added an estimated $12.8M to Alkermes.

  • Woodford Investment Management added most to Alkermes in Q4 2017, an estimated $12.8M increase.
  • Woodford Investment Management's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $6.55M.
  • Woodford Investment Management fully exited AbbVie in Q4 2017, selling an estimated $344M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $1.48B portfolio in Q4 2017.
  • Woodford Investment Management opened 0 new positions and closed 1 in Q4 2017.
  • Woodford Investment Management's portfolio value fell 32% quarter-over-quarter to $1.48B.

Based on Woodford Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.